Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics
Author:
Funder
Puma Biotechnology
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference93 articles.
1. The distinctive nature of HER2-positive breast cancers;Burstein;N Engl J Med,2005
2. Concordance among gene-expression–based predictors for breast cancer;Fan;N Engl J Med,2006
3. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status;Howlader;J Natl Cancer Inst,2014
4. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications;Iqbal;Mol Biol Int,2014
5. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2–positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831;Perez;J Clin Oncol,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab;International Journal of Molecular Sciences;2024-08-27
2. NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity;Cancer Immunology, Immunotherapy;2024-08-08
3. Systemic oncological therapy in breast cancer patients on dialysis;World Journal of Clinical Oncology;2024-06-24
4. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies;Biochemical Pharmacology;2024-05
5. Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients;International Journal of Molecular Sciences;2024-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3